Bioventus, Inc. (BVS)
12.86
-0.34
(-2.58%)
USD |
NASDAQ |
Sep 17, 14:23
Bioventus Price to Book Value : 3.842 for Sept. 17, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 16, 2026 | 3.944 |
| September 15, 2026 | 3.884 |
| September 14, 2026 | 3.932 |
| September 11, 2026 | 3.878 |
| September 10, 2026 | 3.902 |
| September 09, 2026 | 4.072 |
| September 08, 2026 | 4.132 |
| September 04, 2026 | 4.204 |
| September 03, 2026 | 4.290 |
| September 02, 2026 | 4.293 |
| September 01, 2026 | 4.084 |
| August 31, 2026 | 4.078 |
| August 28, 2026 | 4.135 |
| August 27, 2026 | 4.120 |
| August 26, 2026 | 4.174 |
| August 25, 2026 | 4.207 |
| August 24, 2026 | 4.189 |
| August 21, 2026 | 4.296 |
| August 20, 2026 | 4.281 |
| August 19, 2026 | 4.386 |
| August 18, 2026 | 4.272 |
| August 17, 2026 | 4.147 |
| August 14, 2026 | 4.260 |
| August 13, 2026 | 4.15 |
| August 12, 2026 | 4.157 |
| Date | Value |
|---|---|
| August 11, 2026 | 4.138 |
| August 10, 2026 | 4.171 |
| August 07, 2026 | 4.220 |
| August 06, 2026 | 4.177 |
| August 05, 2026 | 4.559 |
| August 04, 2026 | 4.010 |
| August 03, 2026 | 4.024 |
| July 31, 2026 | 3.935 |
| July 30, 2026 | 3.938 |
| July 29, 2026 | 3.920 |
| July 28, 2026 | 3.947 |
| July 27, 2026 | 3.720 |
| July 24, 2026 | 3.526 |
| July 23, 2026 | 3.430 |
| July 22, 2026 | 3.475 |
| July 21, 2026 | 3.549 |
| July 20, 2026 | 3.460 |
| July 17, 2026 | 3.603 |
| July 16, 2026 | 3.714 |
| July 15, 2026 | 3.576 |
| July 14, 2026 | 3.454 |
| July 13, 2026 | 3.606 |
| July 10, 2026 | 3.549 |
| July 09, 2026 | 3.651 |
| July 08, 2026 | 3.618 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Accuray, Inc. | 0.7152 |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 0.8256 |
| ResMed, Inc. | 5.020 |
| Rockwell Medical, Inc. | 0.8887 |
Price to Book Value Related Metrics
| PE Ratio | 16.59 |
| PS Ratio | 1.541 |
| Price to Free Cash Flow | 9.582 |
| Price | 12.86 |
| Earnings Yield | 6.03% |
| Market Cap | 877.20M |
| Operating PE Ratio | 14.60 |
| Normalized PE Ratio | 15.88 |